Načítá se...
USL255 extended-release topiramate: Dose-proportional pharmacokinetics and tolerability in healthy volunteers
OBJECTIVE: Evaluate the pharmacokinetics (PK), safety, and tolerability of single doses of once-daily USL255, Qudexy XR (topiramate) extended-release capsules, over a wide dosing range. METHODS: Two single-dose, phase I studies in healthy adults were used to evaluate the PK profile and maximum toler...
Uloženo v:
| Vydáno v: | Epilepsia |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BlackWell Publishing Ltd
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283972/ https://ncbi.nlm.nih.gov/pubmed/24861853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.12654 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|